Hong Myung Lee

This inventor holds 10 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, Harvard College, Takeda Pharmaceutical Company Limited. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Myung Lee. Retrieved from https://idiyas.com/inventor/hong-myung-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 6)

% Patents Active = 50.0

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 20(Granted Patents)

Company Filing History:

5 out of 854

Millennium Pharmaceuticals Limited

Takeda Pharmaceutical Company Limited

patents

Years Active: 2014-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12221460 - Antibody drug conjugates (2025-02-11),

2. 11725024 - Antibody drug conjugates (2023-08-15),

3. 10323018 - Quinazoline and quinoline compounds and uses thereof (2019-06-18),

4. 10202400 - Cortistatin analogues and syntheses thereof (2019-02-12),

5. 10144742 - Quinoxaline compounds and uses thereof (2018-12-04),

6. 9714255 - Cortistatin analogues and syntheses thereof (2017-07-25),

7. 9127019 - Cortistatin analogues and synthesis thereof (2015-09-08),

8. 9062038 - Heteroaryls and uses thereof (2015-06-23),

9. 8796271 - Heteroaryls and uses thereof (2014-08-05),

10. 8765746 - Heteroaryls and uses thereof (2014-07-01),

Title: The Innovative Contributions of Inventor Hong Myung Lee

Introduction

Hong Myung Lee is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biotechnology. With a total of ten patents to his name, Lee has focused his research on antibody drug conjugates, particularly those that incorporate STING modulators to enhance immune responses.

Latest Patents

Among his latest innovations, Hong Myung Lee has developed antibody drug conjugates that utilize STING modulators. These groundbreaking compositions are designed to stimulate an immune response in subjects who need it, presenting exciting possibilities for therapeutic applications in treating diseases.

Career Highlights

Throughout his career, Hong Myung Lee has collaborated with leading organizations in the biotechnology sector. Notably, he has worked with Millennium Pharmaceuticals Limited and Harvard College, where he has honed his skills and contributed to the advancement of medical science.

Collaborations

Lee's work has also included collaborations with esteemed colleagues such as Zhan Shi and Stepan Vyskocil. Together, they have explored innovative solutions to complex challenges in the realm of antibody therapeutics.

Conclusion

As an inventor, Hong Myung Lee has made a notable mark in the field of biotechnology through his patents and collaborative efforts. His research on antibody drug conjugates continues to pave the way for new therapeutic strategies, showcasing the importance of innovation in addressing critical health issues.

Profile summary based on public USPTO records.